Pharmacy Program Medical Necessity Form for
Nucynta (tapentadol)
This form applies to the US Family Health Plan Mail Order Pharmacy and the US Family Health Plan Retail Pharmacy programs. This form must be completed and signed by
the prescriber.
Nucynta (tapentadol) is a Schedule II high potency opioid analgesic indicated for short-term therapy in the relief of moderate to severe acute pain.
Nucynta is non-formulary, but available to most beneficiaries at the non-formulary cost share. Opioid analgesics on the DoD Uniform Formulary
include Opana (oxymorphone immediate-release) and multiple generics: codeine, hydromorphone, levorphanol, meperidine, methadone, morphine
sulfate immediate-release, and oxycodone immediate-release.
The purpose of this form is to provide information that will be used to determine if the use of Nucynta instead of a formulary medication is medically
necessary. If Nucynta is determined to be medically necessary, non-Active duty beneficiaries may obtain it at the formulary cost share.
• The provider may call:
or the completed form may be faxed to:
• The patient may attach the completed form to the prescription and mail
it to: ATTN: Pharmacy, 77 Warren St, Brighton, MA 02135
Step
Please complete patient and physician information
(please print)
Patient Name:
Physician Name:
1
Address:
Address:
Sponsor ID #
Phone #:
Date of Birth:
Secure Fax #:
Please explain why the patient cannot be treated with a formulary medication:
Step
Please explain why the patient cannot be treated with a formulary medication. A specific written clinical explanation is required
2
for each formulary medication.
Formulary Medication
Reason
Clinical Explanation
Codeine
1
Hydromorphone
1
Levorphanol
1
Meperidine
1
Methadone
1
Morphine sulfate IR
1
Opana (oxymorphone IR)
1
Oxycodone IR
1
Acceptable clinical reasons for not using a formulary medication are:
1.
Use of the formulary opioid analgesic is contraindicated (e.g., due to hypersensitivity).
I certify the above is correct and accurate to the best of my knowledge. Please sign and date:
Step
3
Prescriber Signature
Date
Latest revision: Sept. 28, 2011